2022-502951-77-00已完成1 期
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adults
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CTIS Point of Contact
Scientific
Janssen - Cilag International
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study to Investigate Single Ascending Doses of Ocrelizumab for Safety and Side Effects, How The Body Handles It Over A Period of Time, How The Body Notices and Reacts To It, And Its Effect On The Body When Given As A Subcutaneous Injection In Patients With Multiple Sclerosis2024-513639-26-00F. Hoffmann-La Roche AG44
招募中
1 期
A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults.2024-519327-20-00Boehringer Ingelheim International GmbH48
进行中（未招募）
1 期
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adultsHealthy Adult ParticipantsCTIS2022-502951-77-00Janssen - Cilag International20
进行中（未招募）
1 期
A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinetics) in healthy adults.Bipolar depressionCTIS2023-504055-27-00Janssen - Cilag International48
招募中
1 期
A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinetics) in healthy adults.2023-504055-27-00Janssen - Cilag International48